Showing results (231-240 of 438) with videos related to

Sort By:
Pageof 44
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myelomaR Donald Harvey, Jonathan L Kaufman, Heather R Johnson, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2015
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†C Casulo, B Day, K L Dawson, et al.
Blood Cancer Discovery|February 3, 2025
Addressing Health Disparities in Hematologic Malignancies: from Genes to OutreachChristopher R Flowers, Rachel W Anantha, Veronica Leautaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guidelineChristopher R Flowers, Jerome Seidenfeld, Eric J Bow, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateRandy A Taplitz, Erin B Kennedy, Eric J Bow, et al.
ESMO Open|April 1, 2026
Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.
Leukemia & Lymphoma|February 9, 2018
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort studyChristopher R Flowers, Chadi Nabhan, Neil E Kay, et al.
Blood Advances|February 2, 2018
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonistsChristopher T Petersen, Mojibade Hassan, Anna B Morris, et al.
Pageof 44